• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Saturday, June 6, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

AFP

Indonesians ignore warnings in rush to buy anti-parasite drug for Covid

Published on: July 8, 2021 3:07 PM

Indonesians have ignored health warnings to stock up on a “miracle cure” for Covid-19 backed by leading politicians and social media influencers, as an out-of-control virus surge sweeps the country.

Authorities are reporting hundreds of deaths every day as the world’s fourth-most populous nation struggles with its worst outbreak since the pandemic began. Pharmacies across the country are running out of ivermectin, an oral treatment normally used to treat lice and other parasitic infections, thanks in part to viral social media posts touting its potential as a coronavirus treatment. “Those who come bring a screenshot showing that ivermectin… could cure Covid,” said Yoyon, head of a pharmaceutical sales group at a market in the capital Jakarta, who like many Indonesians goes by one name.

He said the shortage had pushed the price of the drug up from around 175,000 to 300,000 rupiah ($12-$21) a bottle.

“We are out of supplies at the moment after many people came to buy it,” he added. Enthusiastic praise from popular online personalities are helping drive demand. “Ivermectin is one of the safe and effective keys to ending the pandemic from various doctors, with lots of scientific evidence,” Reza Gunawan, a self-described “holistic health practitioner”, wrote to his 350,000 Twitter followers. Iman Sjafei, the cofounder of popular Indonesian media outlet Asumsi, used the same platform to say five of his acquaintances had recovered from Covid after taking the drug. “Maybe placebo. Maybe. But it might be true too,” he added.

Sylvie Bernadi, who lives on Jakarta’s outskirts, said she purchased ivermectin for infected relatives after seeing WhatsApp messages and social media posts promoting the drug. “Many people are saying that it can cure Covid-19 so I bought it,” the 66-year-old said, while conceding some had raised concerns about unspecified side effects. Fuelled by anti-vaccine and pandemic conspiracy theories online, there has been a surge in demand for the drug from Brazil to South Africa to Lebanon. But manufacturer Merck has said there was “no scientific basis for a potential therapeutic effect against Covid-19” and warned of possible safety issues if the drug is administered inappropriately. Scientists, the World Health Organization, and several drug regulators — including Indonesia’s own — have also stressed there is a lack of credible evidence to show it works against Covid-19.

– ‘I’m not a doctor, but…’ –

That has not stopped Indonesian tycoon and government minister Erick Thohir from praising ivermectin and urging domestic production to fight the current outbreak. A former owner of Italian football champions Inter Milan and a shareholder of the Philadelphia 76ers basketball franchise, Thohir recently suggested that state-owned drug giant Indofarma could produce up to four million ivermectin tablets a month. While he said more testing is required to ascertain its effectiveness against Covid-19 and urged users to get a prescription before taking the tablets, others have shown less caution. “I’m not a doctor, but in the midst of desperation and difficulty, I think anything is worth a try,” said Susi Pudjiastuti, a popular former fisheries minister, who has 2.5 million followers on Twitter. Facebook posts and articles touting the drug’s effectiveness against coronavirus have proliferated in several countries. Efforts to tackle the virus worldwide have been marred by conspiracy theories, often propagated by political leaders and other public figures. In the Philippines, President Rodrigo Duterte has pressured regulators to approve the the drug as a Covid treatment.

“There are a lot of credible people… who swear by their fathers’ grave that ivermectin is doing good to their bodies while they are suffering from Covid,” Duterte recently told the chief of the country’s drug regulator. After demand for the drug surged in Latin America, the WHO said in March that any use of the drug as a coronavirus treatment should be limited to clinical trials. The US Food and Drug Administration has even warned of the risks of taking ivermectin following reports of people being hospitalised after ingesting a version of the drug meant for horses.

Filed Under: World Tagged With: Drugs, Health, Indonesia, Latest, virus

Submit a Comment




Primary Sidebar




Latest News

Alexander Zverev eases past Jakub Mensik in French Open semifinals

Taylor to face Pili in Croke Park farewell

FIFA bans vuvuzelas from World Cup stadiums

France brush off Ivory Coast loss, call it timely World Cup reminder

Legendary boxer Muhammad Ali’s 10th death anniversary observed

Pakistan

JAAC declared proscribed party ahead of AJK polls on July 27

Fixed tax scheme for small retailers launched to raise Rs 50bn annually

Govt cuts petrol price by Rs 4 per litre, keeps diesel’s unchanged

Bilawal promises GB voters with land and job rights

Iran declares support for Hezbollah with wider peace deal in doubt

More Posts from this Category

Business

SBP’s ‘Go Cashless’ campaign saw Rs 34bn in digital transactions on Eid

Short-term inflation down by 0.56%

Saudi-Pak Business Council shows interest in infrastructure investment

‘Govt, allies united in efforts to craft people-centric budget’

Rupee records gain against US dollar

More Posts from this Category

World

CENTCOM space post signals wider US military footprint

US official delivers Trump’s “good hello” to Putin

NASA lifts ISS evacuation alert after leak

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.